普甜食品(01699.HK)2018年到期可換股債及不可換股票據到期日延期
格隆匯5月29日丨普甜食品(01699.HK)發佈公告,有關根據認購協議向投資者發行總本金額為1.50億港元5%有抵押可換股債券及發行總本金額為1.10億港元6%有抵押不可換股票據。根據第二次書面確認,到期日的最長延期(如有)已於2019年7月15日屆滿。截至該公佈日期,公司與投資者仍在就修訂平邊契據的條款進行磋商。為提供更多時間進行磋商,2020年5月29日,投資者已同意到期日的進一步延期將為2021年5月31日,且延期及修訂的最終條款將受根據可換股債券及票據的條款作出的相關修訂平邊契據及修訂平邊契據載列的條款所規限。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.